KMTS
Kestra Medical Technologies, Ltd.
NasdaqGS Healthcare United States
27,36 $US
-3.25% today
+12.18% YTD · +3.64% 1Y
12
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
8
Hedge funds tracked
Latest available SEC 13F filings
60
/ 100
STRONG

Analysis Kestra Medical Technologies, Ltd. (KMTS) — Kairos Score 60/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.

Key info

👔
CEO
Mr. Brian Webster
📍
HQ
3933 Lake Washington Blvd NE, Suite 200, Kirkland, WA, 98033, United States
👥
Employees
443
💰
Market cap
1 629 610 752,00 $US
💸
Dividend yield
0.00%

🕴️ Insider activity (90 days)

12 transactions — 0 buys and 6 sales reported by Kestra Medical Technologies, Ltd. executives.

CR
COHEN RAYMOND W
2026-09-30
Sell
KE
Kwo Elizabeth
2026-09-21
Sell
KE
Kwo Elizabeth
2026-09-09
Other

🏦 Hedge Funds

8 institutional funds report a position on KMTS in their latest SEC quarterly filing.

Hood River Capital Management LLC
GEODE CAPITAL MANAGEMENT, LLC
DRIEHAUS CAPITAL MANAGEMENT LLC
Bank of New York Mellon Corp
TUDOR INVESTMENT CORP ET AL

📰 Recent news

15 recent articles on KMTS.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as Kestra Medical Technologies, Ltd.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of KMTS on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 12 insider transactions over 90 days
✅ All 8 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year